Drug discovery for schizophrenia from PNS to CNS and back - Lipina, Tatiana V (Royal Society of Chemistry, 2024)
- Genetic Architecture of Schizophrenia: Transitioning from Candidate Genes to Polygenic Risk Scores; - Psychotic Illness as a Disorder of Subtle, Whole-body Maldevelopment: Challenges and Opportunities for Drug Discovery; - Combinatorial Behavioural Phenotyping of Mouse Models of Schizophrenia; - Beyond Brain Boundaries: The Emerging Significance of Vagal Body-to-brain Communication in Schizophrenia; - Iron Dyshomeostasis in Schizophrenia and Potential Treatments to Mitigate Its Effects; - Smell of Dopamine in Schizophrenia: Towards Drug-discovery; - Aromatherapy: A Novel Approach to Schizophrenia Treatment; - Emerging Non-invasive Brain Stimulations for Schizophrenia; - From Circuits to Drug Targets: The Promise Of Opto- and Chemogenetics for Drug Discovery; - Therapeutic Implications of Recent Genomic Discoveries in Schizophrenia